Related Experiment Video
Updated: Feb 8, 2026

Adoptive Immunotherapy of iNKT Cells in Glucose-6-Phosphate Isomerase G6PI-Induced RA Mice
Published on: January 31, 2020
Hemolysis and Glucose-6-Phosphate Dehydrogenase Deficiency-Related Neonatal Hyperbilirubinemia
Michael Kaplan1,2, Ronald J Wong3, David K Stevenson3
1Shaare Zedek Medical Center (Emeritus), Jerusalem, Israel.
Insights
Hemolysis plays a key role in neonatal hyperbilirubinemia for infants with Glucose-6-phosphate dehydrogenase (G6PD) deficiency. Elevated carbon monoxide levels confirm increased red blood cell breakdown in affected newborns.
Area of Science:
- Neonatology
- Hematology
- Genetics
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency affects over 300 million people globally.
- Neonatal hyperbilirubinemia in G6PD deficiency can lead to severe complications, including bilirubin neurotoxicity and death.
- The exact pathophysiology of jaundice in G6PD-deficient neonates is debated, with some suggesting limited hemolysis.
Purpose of the Study:
- To investigate the contribution of hemolysis to neonatal hyperbilirubinemia in cases of G6PD deficiency.
- To clarify the role of red blood cell breakdown in the development of severe jaundice in newborns with G6PD deficiency.
Main Methods:
- A review of previously published studies was conducted.
- Focus was placed on research examining endogenous carbon monoxide (CO) production, a marker of heme catabolism, in hyperbilirubinemic neonates with G6PD deficiency.
Main Results:
- Three reviewed studies indicated elevated endogenous CO production in G6PD-deficient neonates experiencing extreme hyperbilirubinemia.
- This finding suggests increased heme breakdown, indicative of hemolysis.
Conclusions:
- Hemolysis is confirmed as a significant pathogenetic factor in neonatal hyperbilirubinemia associated with G6PD deficiency.
- Understanding the role of hemolysis is crucial for managing severe jaundice in these infants.
Background:
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a common enzyme deficiency affecting more than 300 million individuals worldwide. Extreme neonatal hyperbilirubinemia, with its severe sequelae of bilirubin neurotoxicity and the potential of death, is the most devastating manifestation of G6PD deficiency. In a recent review of Favism, Luzzatto and Arese state that the pathophysiology of jaundice in G6PD-deficient neonates is different from that of favism, as there is little evidence of hemolysis in these infants.
Objectives:
To explore the role of hemolysis in neonatal hyperbilirubinemia associated with G6PD deficiency.
Methods:
Previously published works including studies of endogenous production of carbon monoxide (CO), an index of heme catabolism, in hyperbilirubinemic G6PD-deficient neonates were reviewed to determine the role of hemolysis in this condition.
Results:
Three studies demonstrated that endogenous CO production is elevated in G6PD-deficient neonates with extreme hyperbilirubinemia.
Conclusions:
Hemolysis is an important pathogenetic factor in G6PD deficiency-associated neonatal hyperbilirubinemia.
More Related Videos
Related Concept Videos
Phosphate Buffer
Sodium dihydrogen phosphate does not fully dissociate in neutral or acidic solutions. When a strong base, such as sodium hydroxide (NaOH), is introduced into the solution, sodium dihydrogen phosphate...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily...
Glucose Absorption Into the Small Intestine
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...

